Ironwood Pharmaceuticals
IRWD
IRWD
156 hedge funds and large institutions have $2.09B invested in Ironwood Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 54 increasing their positions, 44 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
156
Holders Change
+11
Holders Change %
+7.59%
% of All Funds
3.38%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
34
Increased
54
Reduced
44
Closed
23
Calls
$24M
Puts
$8.25M
Net Calls
+$15.8M
Net Calls Change
+$4.12M
Top Buyers
1 |
Wellington Management Group
Boston,
Massachusetts
|
+$27.7M |
2 |
Citadel Advisors
Miami,
Florida
|
+$24.8M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.4M |
4 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$17.5M |
5 |
HM
HealthCor Management
New York
|
+$10.1M |
Top Sellers
1 |
O
OrbiMed
New York
|
-$29.8M |
2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$13.3M |
3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$12M |
4 |
Millennium Management
New York
|
-$6.83M |
5 |
UBS Group
Zurich,
Switzerland
|
-$5.2M |